共 42 条
- [1] Panhuizen IF(2015)Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment Br J Anaesth 114 777-784
- [2] Gold SJ(2016)The use of rocuronium and sugammadex in paediatric renal transplantation: two case reports Eur J Anaesthesiol 33 383-386
- [3] Buerkle C(2015)Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: a comparative prospective clinical trial Eur J Anaesthesiol 32 681-686
- [4] Snoeck MM(2007)Sugammadex: another milestone in clinical neuromuscular pharmacology Anesth Analg 104 575-581
- [5] Harper NJ(2008)Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function Br J Anaesth 101 492-497
- [6] Kaspers MJ(2010)Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study Br J Anaesth 104 31-39
- [7] van den Heuvel MW(2014)Three suspected cases of sugammadex-induced anaphylactic shock BMC Anesthesiol 14 92-691
- [8] Hollmann MW(2016)Use of rocuronium and sugammadex in renal transplantation: problems that must be considered Eur J Anaesthesiol 33 690-undefined
- [9] Carlos RV(undefined)undefined undefined undefined undefined-undefined
- [10] Torres ML(undefined)undefined undefined undefined undefined-undefined